blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0238407

EP0238407 - Industrial processes for the manufacture of ribosomal vaccines, and ribosomal vaccines so obtained [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.1993
Database last updated on 06.07.2024
Most recent event   Tooltip10.06.1993No opposition filed within time limitpublished on 28.07.1993 [1993/30]
Applicant(s)For all designated states
PIERRE FABRE MEDICAMENT
45, Place Abel Gance
92100 Boulogne / FR
[N/P]
Former [1992/20]For all designated states
PIERRE FABRE MEDICAMENT
45, Place Abel Gance
F-92100 Boulogne / FR
Former [1989/17]For all designated states
PIERRE FABRE MEDICAMENT
125, Rue de la Faisanderie
F-75116 Paris / FR
Former [1987/39]For all designated states
PIERRE FABRE MEDICAMENT
125 rue de la Faisanderie
F-75116 Paris / FR
Inventor(s)01 / Dussourd D'Hinterland, Lucien
Domaine de Plombière
F-81100 Castres / FR
02 / Normier, Gérard
23, rue Francis Poulenc
F-81100 Castres / FR
03 / Pinel, Anne-Marie
22, rue des Capucins
F-81100 Castres / FR
04 / Durand, Jacques
19, rue des Grillons
F-81100 Castres / FR
[1987/39]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1987/39]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date87400577.016.03.1987
[1987/39]
Priority number, dateFR1986000382918.03.1986         Original published format: FR 8603829
[1987/39]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0238407
Date:23.09.1987
Language:FR
[1987/39]
Type: B1 Patent specification 
No.:EP0238407
Date:05.08.1992
Language:FR
[1992/32]
Search report(s)(Supplementary) European search report - dispatched on:EP20.07.1987
ClassificationIPC:A61K39/39, A61K35/74, A61K39/02, A61K39/116, A61K39/108, A61K39/102, A61K39/09
[1987/39]
CPC:
A61K39/0266 (EP); A61K39/092 (EP); A61K39/102 (EP);
A61K39/39 (EP); A61K2039/55516 (EP); A61K2039/55561 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1987/39]
TitleGerman:Industrielles Verfahren zur Herstellung ribosomaler Impfstoffe und die so erhaltenen ribosomalen Impfstoffe[1987/39]
English:Industrial processes for the manufacture of ribosomal vaccines, and ribosomal vaccines so obtained[1987/39]
French:Procédés industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus[1987/39]
Examination procedure07.03.1988Examination requested  [1988/18]
18.03.1991Despatch of a communication from the examining division (Time limit: M04)
27.05.1991Reply to a communication from the examining division
18.11.1991Despatch of communication of intention to grant (Approval: Yes)
11.02.1992Communication of intention to grant the patent
14.04.1992Fee for grant paid
14.04.1992Fee for publishing/printing paid
Opposition(s)07.05.1993No opposition filed within time limit [1993/30]
Fees paidRenewal fee
22.02.1989Renewal fee patent year 03
20.02.1990Renewal fee patent year 04
18.02.1991Renewal fee patent year 05
24.02.1992Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]FR2253499  (FABRE SA PIERRE [FR]);
 [YD]FR2305990  (FABRE SA PIERRE [FR]);
 [YD]FR2360314  (FABRE SA PIERRE [FR]);
 [YD]FR2444464  (FABRE SA PIERRE)
 [Y]  - CHEMICAL ABSTRACTS, vol. 104, 1986, page 473, no. 184461w, Columbus, Ohio, US; G. NORMIER et al.: "NK-cell stimulating properties of a membrane proteoglycan from non-capsulated Klebsiella pneumoniae biotype a" & ACTA PATHOL. MICROBIOL. IMMUNOL. SCAND. SECT. C. 1985, 93C(6), 233-43
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.